Transdermal physostigmine—absence of effect on topographic brain mapping

M. Y. Neufeld; F. Mawassi; A. Levy; T. A. Treves; A. D. Korczyn

doi:10.1155/1993/892685

Transdermal physostigmine—absence of effect on topographic brain mapping

M. Y. Neufeld^*, F. Mawassi, A. Levy, T. A. Treves, A. D. Korczyn

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.

Original language	English
Pages (from-to)	33-35
Number of pages	3
Journal	Behavioural Neurology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1155/1993/892685
State	Published - 1993
Externally published	Yes

Keywords

Alzheimer’s disease
Brain mapping
Dementia
EEG
Physostigmine

Access to Document

10.1155/1993/892685

Cite this

@article{2d19013e146f4f7590cf87139bf506cb,

title = "Transdermal physostigmine—absence of effect on topographic brain mapping",

abstract = "Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.",

keywords = "Alzheimer{\textquoteright}s disease, Brain mapping, Dementia, EEG, Physostigmine",

author = "Neufeld, \{M. Y.\} and F. Mawassi and A. Levy and Treves, \{T. A.\} and Korczyn, \{A. D.\}",

year = "1993",

doi = "10.1155/1993/892685",

language = "אנגלית",

volume = "6",

pages = "33--35",

journal = "Behavioural Neurology",

issn = "0953-4180",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Transdermal physostigmine—absence of effect on topographic brain mapping

AU - Neufeld, M. Y.

AU - Mawassi, F.

AU - Levy, A.

AU - Treves, T. A.

AU - Korczyn, A. D.

PY - 1993

Y1 - 1993

N2 - Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.

AB - Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.

KW - Alzheimer’s disease

KW - Brain mapping

KW - Dementia

KW - EEG

KW - Physostigmine

UR - http://www.scopus.com/inward/record.url?scp=85193456013&partnerID=8YFLogxK

U2 - 10.1155/1993/892685

DO - 10.1155/1993/892685

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85193456013

SN - 0953-4180

VL - 6

SP - 33

EP - 35

JO - Behavioural Neurology

JF - Behavioural Neurology

IS - 1

ER -

Transdermal physostigmine—absence of effect on topographic brain mapping

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this